Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells

Cell Stress and Chaperones

Volumn 20, Issue 2, 2015, Pages 217-220

  Zhu, Hongcheng ^a   Yang, Xi ^a   Liu, Jia ^a   Zhou, Lu ^b   Zhang, Chi ^a   Xu, Liping ^a   Qin, Qin ^a   Zhan, Liangliang ^a   Lu, Jing ^a   Cheng, Hongyan ^a   Sun, Xinchen ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Cancer; eEF2; eEF2K; Eukaryotic elongation factor 2 kinase; Stress

Indexed keywords

1 BENZYL 3 CETYL 2 METHYLIMIDAZOLIUM IODIDE; 8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; ANTINEOPLASTIC AGENT; DOXORUBICIN; ELONGATION FACTOR 2 KINASE; ESTROGEN RECEPTOR; EUKARYOTIC ELONGATION FACTOR 2 KINASE; GEFITINIB; LAPATINIB; MESSENGER RNA; PROGESTERONE RECEPTOR; PROTEIN BCL XL; ROTTLERIN; TRASTUZUMAB; UNCLASSIFIED DRUG; ELONGATION FACTOR 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOPHAGY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL STRESS; CLINICAL STUDY; CYTOTOXICITY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLIOMA; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; METABOLIC STRESS; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; GENE SILENCING; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; UPREGULATION;

APOPTOSIS; AUTOPHAGY; ELONGATION FACTOR 2 KINASE; GENE SILENCING; HUMANS; NEOPLASMS; PEPTIDE ELONGATION FACTOR 2; UP-REGULATION;

EID: 84925538530     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-014-0545-0     Document Type: Review

References (28)

1. Ashour AA, Abdel-Aziz AA, Mansour AM et al (2014) Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells. Apoptosis 19:241–258
2. Casado E, Garcia VM, Sánchez JJ et al (2012) Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target. Int J Radiat Oncol Biol Phys 84:1151–1158
3. Chen TJ, Cheng HM, Wang DC et al (2011a) Nonlethal aluminum maltolate can reduce brain-derived neurotrophic factor-induced Arc expression through interrupting the ERK signaling in SH-SY5Y neuroblastoma cells. Toxicol Lett 200:67–76
4. Chen Z, Gopalakrishnan SM, Bui MH et al (2011b) 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. J Biol Chem 286:43951–43958
5. Cheng Y, Ren X, Zhang Y et al (2011) eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res 71:2654–2663
6. Devkota AK, Tavares CD, Warthaka M et al (2012) Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact. Biochemistry 51:2100–2112
7. Ferdek PE, Gerasimenko JV, Peng S et al (2012) A novel role for Bcl-2 in regulation of cellular calcium extrusion. Curr Biol 22:1241–1246
8. Gills JJ, Lopiccolo J, Dennis PA (2008) Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy. Autophagy 4:107–109
9. Grandjean M, Sermeus A, Branders S et al (2013) Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers. PLoS One 8:e76508
10. Hizli AA, Chi Y, Swanger J et al (2013) Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase. Mol Cell Biol 33:596–604
11. Kenney JW, Moore CE, Wang X et al (2014) Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles. Adv Biol Regul 55:15–27
12. Kurata S, Shen B, Liu JO et al (2013) Possible steps of complete disassembly of post-termination complex by yeast eEF3 deduced from inhibition by translocation inhibitors. Nucleic Acids Res 41:264–276
13. Leprivier G, Remke M, Rotblat B et al (2013) The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 153:1064–1079
14. Mencalha AL, Corrêa S, Abdelhay E (2014) Role of calcium-dependent protein kinases in chronic myeloid leukemia: combined effects of PKC and BCR-ABL signaling on cellular alterations during leukemia development. Onco Targets Ther 7:1247–1254
15. Meric-Bernstam F, Chen H, Akcakanat A et al (2012) Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer. Breast Cancer Res 14:R138
16. Monteggia LM, Gideons E, Kavalali ET et al (2013) The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine. Biol Psychiatry 73:1199–1203
17. Niu M, Klingler-Hoffmann M, Brazzatti JA et al (2013) Comparative proteomic analysis implicates eEF2 as a novel target of PI3Kgamma in the MDA-MB-231 metastatic breast cancer cell line. Proteome Sci 11:4
18. Pyr Dit Ruys S, Wang X, Smith EM et al (2012) Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase. Biochem J 442:681–692
19. Smith EM, Proud CG (2008) cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner. EMBO J 27:1005–1016
20. Sun HG, Dong XJ, Lu T et al (2013) Clinical value of eukaryotic elongation factor 2 (eEF2) in non-small cell lung cancer patients. Asian Pac J Cancer Prev 14:6533–6535
21. Tekedereli I, Alpay SN, Tavares CD et al (2012) Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer. PLoS One 7:e41171
22. White-Gilbertson S, Kurtz DT, Voelkel-Johnson C (2009) The role of protein synthesis in cell cycling and cancer. Mol Oncol 3:402–408
23. Wu H, Yang JM, Jin S et al (2006) Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Cancer Res 66:3015–3023
24. Wullner U, Neef I, Eller A et al (2008) Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. Curr Cancer Drug Targets 8:554–565
25. Yang CW, Lee YZ, Hsu HY et al (2013) c-Jun-mediated anticancer mechanisms of tylophorine. Carcinogenesis 34:1304–1314
26. Zhang H, Bialkowska A, Rusovici R et al (2007) Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Kruppel-like factor 5. J Biol Chem 282:15541–15549
27. Zhang Y, Cheng Y, Zhang L et al (2011) Inhibition of eEF-2 kinase sensitizes human glioma cells to TRAIL and down-regulates Bcl-xL expression. Biochem Biophys Res Commun 414:129–134
28. Zheng Q, Ye J, Cao J (2014) Translational regulator eIF2α in tumor. Tumour Biol 35:6255–6264